» Articles » PMID: 29089646

Automated Database-guided Expert-supervised Orientation for Immunophenotypic Diagnosis and Classification of Acute Leukemia

Abstract

Precise classification of acute leukemia (AL) is crucial for adequate treatment. EuroFlow has previously designed an AL orientation tube (ALOT) to guide towards the relevant classification panel (T-cell acute lymphoblastic leukemia (T-ALL), B-cell precursor (BCP)-ALL and/or acute myeloid leukemia (AML)) and final diagnosis. Now we built a reference database with 656 typical AL samples (145 T-ALL, 377 BCP-ALL, 134 AML), processed and analyzed via standardized protocols. Using principal component analysis (PCA)-based plots and automated classification algorithms for direct comparison of single-cells from individual patients against the database, another 783 cases were subsequently evaluated. Depending on the database-guided results, patients were categorized as: (i) typical T, B or Myeloid without or; (ii) with a transitional component to another lineage; (iii) atypical; or (iv) mixed-lineage. Using this automated algorithm, in 781/783 cases (99.7%) the right panel was selected, and data comparable to the final WHO-diagnosis was already provided in >93% of cases (85% T-ALL, 97% BCP-ALL, 95% AML and 87% mixed-phenotype AL patients), even without data on the full-characterization panels. Our results show that database-guided analysis facilitates standardized interpretation of ALOT results and allows accurate selection of the relevant classification panels, hence providing a solid basis for designing future WHO AL classifications.

Citing Articles

Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry.

Ally F, Chen X Cancers (Basel). 2024; 16(22).

PMID: 39594810 PMC: 11592599. DOI: 10.3390/cancers16223855.


A Chronological Overview of Using Deep Learning for Leukemia Detection: A Scoping Review.

Rubinos Rodriguez J, Fernandez S, Swartz N, Alonge A, Bhullar F, Betros T Cureus. 2024; 16(5):e61379.

PMID: 38947677 PMC: 11214573. DOI: 10.7759/cureus.61379.


Novel Tools for Diagnosis and Monitoring of AML.

Guijarro F, Garrote M, Villamor N, Colomer D, Esteve J, Lopez-Guerra M Curr Oncol. 2023; 30(6):5201-5213.

PMID: 37366878 PMC: 10297692. DOI: 10.3390/curroncol30060395.


Quality Assessment of a Large Multi-Center Flow Cytometric Dataset of Acute Myeloid Leukemia Patients-A EuroFlow Study.

Bras A, Matarraz S, Nierkens S, Fernandez P, Philippe J, Aanei C Cancers (Basel). 2022; 14(8).

PMID: 35454917 PMC: 9033003. DOI: 10.3390/cancers14082011.


Machine Learning and Deep Learning Applications in Multiple Myeloma Diagnosis, Prognosis, and Treatment Selection.

Allegra A, Tonacci A, Sciaccotta R, Genovese S, Musolino C, Pioggia G Cancers (Basel). 2022; 14(3).

PMID: 35158874 PMC: 8833500. DOI: 10.3390/cancers14030606.


References
1.
van den Ancker W, Terwijn M, Westers T, Merle P, van Beckhoven E, Drager A . Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO2008 classification. Leukemia. 2010; 24(7):1392-6. DOI: 10.1038/leu.2010.119. View

2.
van Dongen J, Lhermitte L, Bottcher S, Almeida J, van der Velden V, Flores-Montero J . EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012; 26(9):1908-75. PMC: 3437410. DOI: 10.1038/leu.2012.120. View

3.
Pedreira C, Costa E, Lecrevisse Q, van Dongen J, Orfao A . Overview of clinical flow cytometry data analysis: recent advances and future challenges. Trends Biotechnol. 2013; 31(7):415-25. DOI: 10.1016/j.tibtech.2013.04.008. View

4.
Flores-Montero J, Sanoja-Flores L, Paiva B, Puig N, Garcia-Sanchez O, Bottcher S . Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia. 2017; 31(10):2094-2103. PMC: 5629369. DOI: 10.1038/leu.2017.29. View

5.
Steiner M, Attarbaschi A, Dworzak M, Strobl H, Pickl W, Kornmuller R . Cytochemically myeloperoxidase positive childhood acute leukemia with lymphoblastic morphology treated as lymphoblastic leukemia. J Pediatr Hematol Oncol. 2009; 32(1):e4-7. DOI: 10.1097/MPH.0b013e3181b1ee65. View